INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Paris Descartes University
París, FranciaPublicaciones en colaboración con investigadores/as de Paris Descartes University (32)
2019
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973
-
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
The Lancet Haematology, Vol. 6, Núm. 12, pp. e638-e649
-
Maximizing binary interactome mapping with a minimal number of assays
Nature Communications, Vol. 10, Núm. 1
-
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 4, pp. 1125-1133.e1
-
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106
-
The Big Data Sjögren consortium: A project for a new data science era
Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23
2018
-
Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia
Leukemia, Vol. 32, Núm. 4, pp. 874-881
-
Effects of metabolic syndrome on arterial function in different age groups: The Advanced Approach to Arterial Stiffness study
Journal of Hypertension, Vol. 36, Núm. 4, pp. 824-833
-
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)
Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111
-
Human endoglin as a potential new partner involved in platelet–endothelium interactions
Cellular and Molecular Life Sciences, Vol. 75, Núm. 7, pp. 1269-1284
2017
-
Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cells
Oncotarget, Vol. 8, Núm. 44, pp. 75797-75807
-
Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future
Cancer Research, Vol. 77, Núm. 6, pp. 1261-1270
-
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
The Lancet Oncology, Vol. 18, Núm. 2, pp. 181-191
-
Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal
EBioMedicine, Vol. 26, pp. 17-24
-
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia
Blood, Vol. 129, Núm. 3, pp. 347-357
2016
-
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; The American Academy of Allergy, Asthma & Immunology; And the European Academy of Allergology and Clinical Immunology
Journal of Allergy and Clinical Immunology, Vol. 137, Núm. 1, pp. 35-45
-
Endoglin regulates mural cell adhesion in the circulatory system
Cellular and Molecular Life Sciences, Vol. 73, Núm. 8, pp. 1715-1739
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
2015
-
KIT mutation analysis in mast cell neoplasms: Recommendations of the European Competence Network on Mastocytosis
Leukemia, Vol. 29, Núm. 6, pp. 1223-1232